IMNM

Immunome, Inc.

7.73 USD

Last updated Dec 9, 04:09 UTC

Yesterday HIGH

$7.92

Yesterday LOW

$7.67

52w HIGH

$9.53

52w LOW

$2.2

EPS

-0.36

PE

-21.47

Next Earnings

Mar 14, 2024

Overview News Insider Transactions Government Trades

Immunome, Inc. stock is down -9.7% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 December’s closed higher than November.

Immunome, Inc. discovers and develops antibody therapeutics for oncology and infectious disease. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

immunome.com

richadhand@benzinga.com

Fri Mar 17, 2023

Chardan Capital Maintains Buy on Immunome, Lowers Price Target to $8

Chardan Capital analyst Matthew Barcus maintains Immunome (NASDAQ:IMNM) with a Buy and lowers the price target from $9 to $8.
Lisa Levin

Fri Jan 6, 2023

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Vandana Singh

Fri Jan 6, 2023

Immunome Stock Jumps On Discovery Pact With AbbVie
Lisa Levin

Fri Jan 6, 2023

Dow Rises Over 300 Points; US Adds 223,000 Jobs In December

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.
Benzinga Newsdesk

Fri Jan 6, 2023

Immunome Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 14.4%
Benzinga Newsdesk

Fri Jan 6, 2023

Immunome Shares Halted On Circuit Breaker To The Downside, Stock Now Up 9.34%
Bill Haddad

Fri Jan 6, 2023

AbbVie And Immunome Announce Collaboration To Discover Multiple Novel Oncology Targets; Immunome To Receive $30M Upfront Payment With Potential For Milestones And Royalties
Lisa Levin

Wed Nov 30, 2022

Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session

Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.
Benzinga Newsdesk

Mon Nov 14, 2022

Immunome Q3 EPS $(0.75) Down From $(0.65) YoY

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.75) per share. This is a 15.38 percent decrease over losses of $(0.65) per share from the same period last year.
Benzinga Newsdesk

Mon Nov 7, 2022

Immunome Presents Preclinical Data On Novel Anti-EPN1 Antibody IMM20059 At The Society For Immunotherapy Of Cancer's 37th Annual Meeting

- IMM20059, Immunome's epsin 1 (EPN1)-specific antibody, binds to the surface of multiple tumor cell lines, including lung, breast and prostate cancers in preclinical testing - - EPN1 appears to play an important

Higgins Jack, Chief Scientific Officer

Fri Dec 1, 2023

IMNM Recent Insider Trades and Stock Chart

200,000 shares awarded
BIENAIME JEAN JACQUES, Director

Tue Nov 7, 2023

IMNM Recent Insider Trades and Stock Chart

40,696 shares awarded